Bon Natural Life Ltd
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Bon Natural Life
Medicinal Chemicals & Botanical Products, SIC 2833
Bon Natural Life Limited is a holding company that operates primarily through its operating subsidiaries in the People's Republic of China. The company engages in the research, development, manufacture, and commercialization of specialized plant-extracted natural ingredients. Its core product portfolio comprises three principal categories: fragrance compounds, health supplements, and bioactive food ingredients. These offerings are distributed to manufacturer and wholesale customers across various downstream consumer markets.
The company maintains operational presence and subsidiaries across multiple locations, including Xi'an, Tongchuan, Dali County, Guangzhou, and Hangzhou in China, alongside corporate entities organized in the Cayman Islands, Hong Kong, and Nevada in the United States. Its principal executive offices are headquartered in Xi'an, Shaanxi Province, China.
Summary of the business section of Bon Natural Life's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Bon Natural Life Ltd
- Headquarters
- Shaanxi, F4
- Address
- Room 601, Block C, Gazelle Valley, No.69, Jinye Road, High-Tech Zone, Xian 710076
- Phone
- 0086-29-88346301
- Employees
- 96, Sep 30, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- E9
- Fiscal year ends
- September 30
- Auditor
- YCM CPA INC, Irvine, California
Stock & identifiers
- Ticker
- BON
- Exchange
- Nasdaq
- IPO date
- Jun 25, 2021
- Shares outstanding
- 8M, Sep 30, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-25 reverse, May 19, 2025; 1-for-10 reverse, Apr 11, 2024
- SEC CIK
- 1816815
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| jing liu | Chief Technology Officer, Director | 1,496 |
| Yongwei Hu | Chief Executive Officer, Director | 80,177 |
| Yingchun Xue | Chief Operating Officer | 120 |
| Xin Ma | Chief Financial Officer | – |
| Chen Wenjuan | Chief Marketing Officer | 80 |
| Gao Zhixiang | Director | – |
| Jing Veronica Chen | Director | – |
| Jianjun Gao | Director | – |
Employees
Headcount reported in annual reports
“of September 30, 2025, we had a total of 96 full time employees, of which 50 are in production, 5 are in quality control, 15 are in R&D,”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 30, 2024 | Late filing | Notification of late filing |
| Jan 31, 2023 | Late filing | Notification of late filing |
| Jun 25, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Jun 21, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |